Evaluation of nootropic activity of smrithi: a polyherbal formulation

In the present study ‘Smrithi’ selected for evaluation of its nootropic activity in different experimental animal models like Scopolamine induced cognitive deficits in mice on Elevated plus maze (EPM) and Morris water maze (MWM) tasks. Smrithi was administered for seven days at the dose of 100 and 2...

Full description

Saved in:
Bibliographic Details
Published inThe pharma innovation Vol. 3; no. 3, Part A; p. 33
Main Authors Vadthya, Jyothi, Satyavati, D, Pradeep Kumar C, Reddy, Ch Maheshwara
Format Journal Article
LanguageEnglish
Published New Delhi The Pharma Innovation 01.05.2014
Subjects
Animal memory
Cognitive enhancement
Rodents
Online AccessGet full text

Cover

More Information
Summary:In the present study ‘Smrithi’ selected for evaluation of its nootropic activity in different experimental animal models like Scopolamine induced cognitive deficits in mice on Elevated plus maze (EPM) and Morris water maze (MWM) tasks. Smrithi was administered for seven days at the dose of 100 and 200 mg/kg body weight, scopolamine (0.3 mg/kg) was used to induce amnesia, piracetam (50 mg/kg) and Mentat (1and 2 ml/kg) served as reference standards. Smrithi treated animals significantly (p<0.01) reduce the Transfer latency on Elevated plus maze and Escape latency in Morris water maze when compared with that of standard nootropic Piracetam, standard polyherbal formulation Mentat and a control group of animals. The probable mechanism of action of Smrithi might be due to its ability to elevate Acetylcholine levels by significant reduction of Acetylcholinesterase enzyme activity in the brain and ultimately improved memory. In the light of above, it may be worthwhile to explore the potential of this formulation in the management of Alzheimer’s patients.
ISSN:2277-7695